Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Harliku™ (nitisinone) – New indication, new formulation
June 10, 2025 - The FDA approved Cycle Pharmaceuticals’ Harliku (nitisinone) tablets, for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria (AKU).
